{"originalText": "2011年10月31日行左半结肠切除、直肠癌切除（HARTTMANN）术，术后直肠残端漏，行腹盆腔冲洗引流术，术后行希罗达化疗。此次复查腹盆腔CT提示：1、直肠、左半结肠切除术后，骶前低密度区范围同前，现约36X23MM（IM112），其周围多发索条影同前。左半结肠吻合口未见增厚及异常强化。右上腹造瘘口未见异常强化。2、肝多发转移灶较前增多、增大，如原较大约20X18MM（IM55），现约42X31MM（IM49）现较大病变约为54X43MM（IM55）。肝囊肿较前无变化，现约24X20MM（IM57）。3、腹膜、网膜及系膜增厚，并见小结节灶，约为9MM（IM67），腹腔内见腹水。腹主动脉内斑块影较前略大（IM57）。\\U007F4、左肾盂、下段输尿管轻度扩张缓解，两肾小囊肿、膀胱前壁增厚同前。脾、胰腺、胆囊、肾下腺、前列腺、精囊腺未见异常。\\U007F5、腹腔、腹膜后、盆腔未见肿大淋巴结。扫及诸骨未见明确骨质破坏征象。此次肿瘤标志物较2012-8均明显升高。\\U0004\\U0004。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 12, "end_pos": 36}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 44}, {"end_pos": 54, "label_type": "手术", "overlap": 0, "start_pos": 46}, {"end_pos": 61, "label_type": "药物", "overlap": 0, "start_pos": 58}, {"label_type": "影像检查", "overlap": 0, "start_pos": 68, "end_pos": 73}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 78, "end_pos": 89}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 257, "end_pos": 258}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 294}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 337, "end_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 345}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 371, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 387, "end_pos": 388}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}]}
{"originalText": "，患者1+月前因子宫纵隔行宫腔镜子宫纵隔电切术。，术前查TCT示：低度鳞状下皮内病变。，术后复查行阴道镜宫颈活检病理示：慢性宫颈炎，部分鳞状下皮增生活跃，符合低级别鳞状下皮内病变，局灶不除外高级别鳞状下皮内瘤变（CINII）；，免疫组化：P16（局部鳞状下皮及腺体鳞状下皮全层+），KI67+,结合HE形态，结果支持局部高级别鳞状下皮内病变（CINII），累及腺体。患者术后阴道流血淋漓不净，无腹痛，无接触性出血。为求进一步治疗来我院就诊，门诊遂以“宫颈病变”收入院。患者自发病以来，无头晕、乏力，无恶心、呕吐，无腹痛、腹泻，饮食睡眠可，大小便无异常，体重无增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 12}, {"end_pos": 23, "label_type": "手术", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 33, "end_pos": 42}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 60, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 112}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 177}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 225, "end_pos": 229}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}]}
{"originalText": "，2014-2-24因发现结肠癌行腹腔镜上乙状结肠癌根治术，，术中见：肿物位于腹膜返折以下，大小约2.8*5.5CM。，术后病理：乙状结肠中分化腺癌，侵透固有肌层达浆膜上脂肪组织；切缘（-）；淋巴结转移10/31；未见脉管癌栓及神经侵犯。，免疫组化：MSI IHC(+);MSH-2(+);KSH(+);PMS-2（+）;KRAS突变型。术后恢复可。术后XELOX方案8周期。末次化疗2014.8.定期复查,2016.2复查CT示右侧髂血管旁淋巴结转移,CA199升高。现口服希罗达化疗约2周期停药.。", "entities": [{"label_type": "疾病和诊断", "start_pos": 13, "end_pos": 16}, {"end_pos": 29, "label_type": "手术", "start_pos": 17}, {"label_type": "解剖部位", "start_pos": 39, "end_pos": 40}, {"label_type": "疾病和诊断", "start_pos": 65, "end_pos": 74}, {"label_type": "影像检查", "start_pos": 212, "end_pos": 214}, {"label_type": "疾病和诊断", "start_pos": 215, "end_pos": 226}, {"label_type": "实验室检验", "start_pos": 226, "end_pos": 232}, {"end_pos": 241, "label_type": "药物", "start_pos": 238}]}
{"originalText": "入院前10月，患者服用“头痛粉”后解黑色成形大便，共3次，量约250g/次，伴头昏、乏力、皮肤黏膜苍白，无反酸、嗳气、烧心，无呕血、腹痛、腹胀、腹泻，无恶心、呕吐、晕厥，无口干、颜面肢体水肿、腹围增大。于我院查“Hb32g/L”，诊断为“1、消化道出血原因待查 2、重度贫血3、肝硬化4、慢性丙型肝炎”，拒绝行胃镜检查，给予止血、纠正贫血、抑酸等对症治疗，未解黑便后自动出院。2月前，患者无明显诱因再次出现解黑便，为黑色糊状大便，每天1次，每次量约100-150g，伴头昏、乏力、心悸。于我院查“Hb 53 g/L，无痛胃镜示胃底静脉曲张（1条），F1，红色征阴性；胃体黏膜隆起，不除外静脉曲张；十二指肠球炎”，下消化道出血原因不能明确，给予止血、纠正贫血、抑酸等对症处理后症状好转出院，未再正规检查及治疗。2天前，患者无明显诱因再次出现解黑大便1次，呈糊状，量约100g，无黏液脓血，伴乏力、头昏，于**医院输液治疗后无明显好转（具体不详），遂于我院就诊，拟“下消化道出血”收入住院。病程中精神、睡眠欠佳，饮食尚可，大便如下述，小便正常。体重无明显减轻。", "entities": [{"label_type": "药物", "overlap": 0, "start_pos": 12, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 106, "end_pos": 108}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 121, "end_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 144, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 241}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 248, "end_pos": 250}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 263, "end_pos": 269}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 285}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 293, "end_pos": 297}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 306, "end_pos": 318}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 397, "end_pos": 398}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 431, "end_pos": 437}]}
{"originalText": "，缘于5月余前因“胃癌”行“腹腔镜上根治性远端胃大部切除术”（2015-08-06），，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜未见明显转移结节，肝脏质地大小正常，未见明显肿物，胆囊无肿大。胃体小弯侧隐约可见病灶，可疑浸润型癌侵及浆膜层，周围见肿大淋巴结。术顺，术后恢复可。术后病理（201528816），：(远端胃)，：胃体小弯溃疡型低粘附性癌，部分为印戒细胞癌，侵及浆膜层。手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结25/25个，大弯淋巴结3/9个，幽门下淋巴结2/2个，幽门上淋巴结6/6个，及另送(第8组)淋巴结1/1个，(第12组)淋巴结1/1个，见癌转移。，免疫组化：KI67（10%+），CK7（-），CK20（+++），VILLIN（+++），CDX-2（+++），CEA（+++），CD56（-），CGA（-），SYN（-），E-CADHERIN（++），HER-2（+），PT4AN3M0IIIC期。排除化疗前禁忌，于2015.09.23、2015.10.26按“卡培他滨片(希罗达)1500MG口服BID+多柔比星脂质体(里葆多)注40MG静滴(基)+奥沙利铂(乐沙定)200MG静滴”方案化疗，2015.12.23予“艾奕60MG口服D1-14+艾恒200MGD1+里葆多40MG静滴D1方案”化疗，并辅以止吐、制酸、保肝、增强免疫等治疗。化疗过程顺利，无明显化疗不良反应。今为返院行第4周期化疗就诊我院，门诊拟以“胃癌术后化疗”收入院。自发病以来，精神、睡眠、食欲尚可，大小便正常，体征无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 29, "label_type": "手术", "overlap": 0, "start_pos": 14}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 156, "end_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 459, "label_type": "药物", "overlap": 0, "start_pos": 454}, {"end_pos": 463, "label_type": "药物", "overlap": 0, "start_pos": 460}, {"end_pos": 483, "label_type": "药物", "overlap": 0, "start_pos": 476}, {"end_pos": 487, "label_type": "药物", "overlap": 0, "start_pos": 484}, {"end_pos": 503, "label_type": "药物", "overlap": 0, "start_pos": 499}, {"end_pos": 507, "label_type": "药物", "overlap": 0, "start_pos": 504}, {"end_pos": 535, "label_type": "药物", "overlap": 0, "start_pos": 533}, {"end_pos": 549, "label_type": "药物", "overlap": 0, "start_pos": 547}, {"end_pos": 560, "label_type": "药物", "overlap": 0, "start_pos": 557}, {"end_pos": 585, "label_type": "解剖部位", "overlap": 0, "start_pos": 584}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 632, "end_pos": 636}]}
